AHR and neoplasm: Many commonly used pharmaceuticals exhibit AhR activity [50] and several of these compounds including tranilast, raloxifene, leflunomide, OME, and flutamide have been characterized as SAhRMs and inhibited tumor growth [44,45,51,52,53].